메뉴 건너뛰기




Volumn 59, Issue 12, 2010, Pages 1033-1040

The effect of the expression of angiotensin II on extracellular matrix metalloproteinase inducer (EMMPRIN) in macrophages is mediated via the AT1/COX-2/PGE2 pathway

Author keywords

Angiotensin II; Extracellular matrix metalloproteinase inducer; Losartan; Macrophage; PGE2

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANGIOTENSIN II; BETA ACTIN; CD147 ANTIGEN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; LOSARTAN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2;

EID: 78651305983     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0223-3     Document Type: Article
Times cited : (10)

References (41)
  • 1
    • 0036605095 scopus 로고    scopus 로고
    • Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts
    • Kanekura T, Chen X, Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer. 2002;99:520-8.
    • (2002) Int. J. Cancer , vol.99 , pp. 520-528
    • Kanekura, T.1    Chen, X.2    Kanzaki, T.3
  • 2
    • 0028795147 scopus 로고
    • The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily
    • Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 1995;55:434-9.
    • (1995) Cancer Res. , vol.55 , pp. 434-439
    • Biswas, C.1    Zhang, Y.2    DeCastro, R.3    Guo, H.4    Nakamura, T.5    Kataoka, H.6
  • 3
    • 0032443309 scopus 로고    scopus 로고
    • Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38
    • Lim M, Martinez T, Jablons D, Cameron R, Guo H, Toole B, et al. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett. 1998;441:88-92.
    • (1998) FEBS Lett. , vol.441 , pp. 88-92
    • Lim, M.1    Martinez, T.2    Jablons, D.3    Cameron, R.4    Guo, H.5    Toole, B.6
  • 4
    • 0037392052 scopus 로고    scopus 로고
    • Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells
    • Yang JM, Xu Z, Wu H, Zhu H, Wu X, Hait WN. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res. 2003;1:420-7.
    • (2003) Mol. Cancer Res. , vol.1 , pp. 420-427
    • Yang, J.M.1    Xu, Z.2    Wu, H.3    Zhu, H.4    Wu, X.5    Hait, W.N.6
  • 5
    • 0036066346 scopus 로고    scopus 로고
    • Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma
    • Major T, Liang L, Lu X. Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma. Arterioscler Thromb Vasc Biol. 2002;22:1200-7.
    • (2002) Arterioscler Thromb. Vasc. Biol. , vol.22 , pp. 1200-1207
    • Major, T.1    Liang, L.2    Lu, X.3
  • 6
    • 20144389430 scopus 로고    scopus 로고
    • Upstream regulation of matrix metalloproteinase by EMM-PRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque
    • Yoon YW, Kwon HM, Hwang KC, Choi EY, Hong BK, Kim D, et al. Upstream regulation of matrix metalloproteinase by EMM-PRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque. Atherosclerosis. 2005;180:37-44.
    • (2005) Atherosclerosis , vol.180 , pp. 37-44
    • Yoon, Y.W.1    Kwon, H.M.2    Hwang, K.C.3    Choi, E.Y.4    Hong, B.K.5    Kim, D.6
  • 7
    • 23244451640 scopus 로고    scopus 로고
    • Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK
    • Hagemann T, Wilson J, Kulbe H. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol. 2005;175:1197-205.
    • (2005) J. Immunol. , vol.175 , pp. 1197-1205
    • Hagemann, T.1    Wilson, J.2    Kulbe, H.3
  • 8
    • 30944460859 scopus 로고    scopus 로고
    • C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: Inhibitory effect of fluvastatin
    • Abe N, Osanai T, Fujiwara T, Kameda K, Matsunaga T, Okumura K. C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: inhibitory effect of fluvastatin. Life Sci. 2006;78:1021-8.
    • (2006) Life Sci. , vol.78 , pp. 1021-1028
    • Abe, N.1    Osanai, T.2    Fujiwara, T.3    Kameda, K.4    Matsunaga, T.5    Okumura, K.6
  • 9
    • 33644861241 scopus 로고    scopus 로고
    • Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: Implications in acute myocardial infarction
    • Schmidt R, Bultmann A, Ungerer M. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction. Circulation. 2006;113:834-41.
    • (2006) Circulation , vol.113 , pp. 834-841
    • Schmidt, R.1    Bultmann, A.2    Ungerer, M.3
  • 10
    • 0037180771 scopus 로고    scopus 로고
    • Inflammation in atherosclerosis
    • Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-74.
    • (2002) Nature , vol.420 , pp. 868-874
    • Libby, P.1
  • 11
    • 33749102228 scopus 로고    scopus 로고
    • Atherosclerosis as an inflammatory disease: Implications for therapy
    • Eldika N, Yerra L, Chi DS, Krishnaswamy G. Atherosclerosis as an inflammatory disease: implications for therapy. Front Biosci. 2004;9:2764-77.
    • (2004) Front Biosci. , vol.9 , pp. 2764-2777
    • Eldika, N.1    Yerra, L.2    Chi, D.S.3    Krishnaswamy, G.4
  • 12
    • 0034846702 scopus 로고    scopus 로고
    • Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation
    • McEver RP. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost. 2001;86:746-56.
    • (2001) Thromb. Haemost. , vol.86 , pp. 746-756
    • McEver, R.P.1
  • 13
    • 43049157965 scopus 로고    scopus 로고
    • Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives
    • Cipollone F, Cicolini G, Bucci M. Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives. Pharmacol Ther. 2008;118:161-80.
    • (2008) Pharmacol. Ther. , vol.118 , pp. 161-180
    • Cipollone, F.1    Cicolini, G.2    Bucci, M.3
  • 17
    • 0035928784 scopus 로고    scopus 로고
    • Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaquesasa basis of prostaglandin E (2)-dependent plaque instability
    • Cipollone F, Prontera C, Pini B, Marini M, Fazia M, De Cesare D, et al. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaquesasa basis of prostaglandin E (2)-dependent plaque instability. Circulation. 2001;104:921-7.
    • (2001) Circulation , vol.104 , pp. 921-927
    • Cipollone, F.1    Prontera, C.2    Pini, B.3    Marini, M.4    Fazia, M.5    De Cesare, D.6
  • 18
    • 0037465733 scopus 로고    scopus 로고
    • Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatindependent plaque stabilization in humans
    • Cipollone F, Fazia M, Iezzi A, Zucchelli M, Pini B, De Cesare D, et al. Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatindependent plaque stabilization in humans. Circulation. 2003;107:1479-85.
    • (2003) Circulation , vol.107 , pp. 1479-1485
    • Cipollone, F.1    Fazia, M.2    Iezzi, A.3    Zucchelli, M.4    Pini, B.5    De Cesare, D.6
  • 19
    • 12144289317 scopus 로고    scopus 로고
    • Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity
    • Cipollone F, Fazia M, Iezzi A, Pini B, Cuccurullo C, Zucchelli M, et al. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity. Circulation. 2004;109:1482-8.
    • (2004) Circulation , vol.109 , pp. 1482-1488
    • Cipollone, F.1    Fazia, M.2    Iezzi, A.3    Pini, B.4    Cuccurullo, C.5    Zucchelli, M.6
  • 20
    • 0034688194 scopus 로고    scopus 로고
    • The heart outcomes prevention evaluation study investigators effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
    • Yusuf S, Sleiht P, Pogue J. The Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145-53.
    • (2000) N. Engl. J. Med. , vol.342 , pp. 145-153
    • Yusuf, S.1    Sleiht, P.2    Pogue, J.3
  • 22
    • 0042330455 scopus 로고    scopus 로고
    • Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
    • Fox K. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782-7.
    • (2003) Lancet , vol.362 , pp. 782-787
    • Fox, K.1
  • 23
    • 0034724305 scopus 로고    scopus 로고
    • Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability
    • Schieffer B, Schieffer E, Hilfiker-Kleiner D. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation. 2000;101:1372-8.
    • (2000) Circulation , vol.101 , pp. 1372-1378
    • Schieffer, B.1    Schieffer, E.2    Hilfiker-Kleiner, D.3
  • 24
    • 0033956858 scopus 로고    scopus 로고
    • Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells
    • Ohnaka K, Numaguchi K, Yamakawa T, Inagami T. Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells. Hypertension. 2000;35:68-75. (Pubitemid 30054239)
    • (2000) Hypertension , vol.35 , Issue.1 , pp. 68-75
    • Ohnaka, K.1    Numaguchi, K.2    Yamakawa, T.3    Inagami, T.4
  • 25
    • 0028826061 scopus 로고
    • Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover
    • Brilla CG, Zhou G, Rupp H, Maisch B, Weber KT. Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. Am J Cardiol. 1995;76:8D-13D.
    • (1995) Am. J. Cardiol. , vol.76
    • Brilla, C.G.1    Zhou, G.2    Rupp, H.3    Maisch, B.4    Weber, K.T.5
  • 26
    • 33847689914 scopus 로고    scopus 로고
    • Optimized THP-1 differentiation is required for the detection of responses to weak stimuli
    • Park EK, Jung HS, Yang HI, Yoo MC, Kim C, Kim KS. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm Res. 2007;56:45-50.
    • (2007) Inflamm. Res. , vol.56 , pp. 45-50
    • Park, E.K.1    Jung, H.S.2    Yang, H.I.3    Yoo, M.C.4    Kim, C.5    Kim, K.S.6
  • 27
    • 0034603775 scopus 로고    scopus 로고
    • Inhibition of early atherogenesis by losartan in monkeys with dietinduced hypercholesterolemia
    • Strawn WB, Chappell MC, Dean RH, Kivlighn S, Ferrario CM. Inhibition of early atherogenesis by losartan in monkeys with dietinduced hypercholesterolemia. Circulation. 2000;101:1586-93.
    • (2000) Circulation , vol.101 , pp. 1586-1593
    • Strawn, W.B.1    Chappell, M.C.2    Dean, R.H.3    Kivlighn, S.4    Ferrario, C.M.5
  • 28
    • 47649093164 scopus 로고    scopus 로고
    • Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice
    • Blessing E, Preusch M, Kranzhofer R, Kinscherf R, Marx N, Rosenfeld ME, et al. Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice. Atherosclerosis. 2008;199:295-303.
    • (2008) Atherosclerosis , vol.199 , pp. 295-303
    • Blessing, E.1    Preusch, M.2    Kranzhofer, R.3    Kinscherf, R.4    Marx, N.5    Rosenfeld, M.E.6
  • 29
    • 30044437012 scopus 로고    scopus 로고
    • Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice
    • Ayabe N, Babaev VR, Tang Y, Tanizawa T, Fogo AB, Linton MF, et al. Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. Atherosclerosis. 2006;184:312-21.
    • (2006) Atherosclerosis , vol.184 , pp. 312-321
    • Ayabe, N.1    Babaev, V.R.2    Tang, Y.3    Tanizawa, T.4    Fogo, A.B.5    Linton, M.F.6
  • 30
    • 0034129997 scopus 로고    scopus 로고
    • Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice
    • Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000;105:1605-12.
    • (2000) J. Clin. Invest. , vol.105 , pp. 1605-1612
    • Daugherty, A.1    Manning, M.W.2    Cassis, L.A.3
  • 31
    • 0037312548 scopus 로고    scopus 로고
    • Matrix metalloproteinases and coronary artery diseases
    • Ikeda U, Shimada K. Matrix metalloproteinases and coronary artery diseases. Clin Cardiol. 2003;26:55-9.
    • (2003) Clin. Cardiol. , vol.26 , pp. 55-59
    • Ikeda, U.1    Shimada, K.2
  • 33
    • 40849140684 scopus 로고    scopus 로고
    • Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells
    • Guo RW, Yang LX, Wang H, Liu B, Wang L. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells. Regul Pept. 2008;147:37-44.
    • (2008) Regul Pept , vol.147 , pp. 37-44
    • Guo, R.W.1    Yang, L.X.2    Wang, H.3    Liu, B.4    Wang, L.5
  • 34
    • 0030871687 scopus 로고    scopus 로고
    • COX-1 and COX-2 tissue expression: Implications and predictions
    • Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol Suppl. 1997;49:15-9.
    • (1997) J. Rheumatol. Suppl. , vol.49 , pp. 15-19
    • Crofford, L.J.1
  • 35
    • 17144454444 scopus 로고    scopus 로고
    • Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions
    • Hong BK, Kwon HM, Lee BK, Kim D, Kim IJ, Kang SM, et al. Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions. Yonsei Med J. 2000;41:82-8.
    • (2000) Yonsei Med. J. , vol.41 , pp. 82-88
    • Hong, B.K.1    Kwon, H.M.2    Lee, B.K.3    Kim, D.4    Kim, I.J.5    Kang, S.M.6
  • 36
    • 0037117652 scopus 로고    scopus 로고
    • Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice
    • Burleigh ME, Babaev VR, Oates JA, Harris RC, Gautam S, Riendeau D, et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation. 2002;105:1816-23.
    • (2002) Circulation , vol.105 , pp. 1816-1823
    • Burleigh, M.E.1    Babaev, V.R.2    Oates, J.A.3    Harris, R.C.4    Gautam, S.5    Riendeau, D.6
  • 38
    • 0031036521 scopus 로고    scopus 로고
    • Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells
    • Guo H, Zucker S, Gordon MK, Toole BP, Biswas C. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem. 1997;272:24-7.
    • (1997) J. Biol. Chem. , vol.272 , pp. 24-27
    • Guo, H.1    Zucker, S.2    Gordon, M.K.3    Toole, B.P.4    Biswas, C.5
  • 39
    • 0034680366 scopus 로고    scopus 로고
    • A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure
    • Spinale FG, Coker ML, Heung LJ. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. 2000;102:1944-9.
    • (2000) Circulation , vol.102 , pp. 1944-1949
    • Spinale, F.G.1    Coker, M.L.2    Heung, L.J.3
  • 40
    • 0034127659 scopus 로고    scopus 로고
    • Myocardial matrix degradation and matrix metalloproteinase activation in the failing heart: A potential therapeutic target
    • Spinale FG, Coker ML, Bond BR, Zellner JL. Myocardial matrix degradation and matrix metalloproteinase activation in the failing heart: a potential therapeutic target. Circ Res. 2000;46:225-38.
    • (2000) Circ. Res. , vol.46 , pp. 225-238
    • Spinale, F.G.1    Coker, M.L.2    Bond, B.R.3    Zellner, J.L.4
  • 41
    • 1842527873 scopus 로고    scopus 로고
    • Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial
    • Brown DL, Desai KK, Vakili BA. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial. Arterioscler Thromb Vasc Biol. 2004;24:733-8.
    • (2004) Arterioscler Thromb. Vasc. Biol. , vol.24 , pp. 733-738
    • Brown, D.L.1    Desai, K.K.2    Vakili, B.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.